Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
06/2005
06/29/2005CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/29/2005CN1208314C Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use
06/28/2005US6911477 Muscarinic receptor agonists
06/28/2005US6911459 Pharmaceutical composition
06/28/2005US6911448 Piperazine and piperidine compounds
06/28/2005CA2152280C Use of riluzole as a radiorestorer
06/23/2005WO2005057171A2 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
06/23/2005WO2005056542A1 Compositions comprising an hiv protease inhibitor
06/23/2005WO2005056537A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same
06/23/2005WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005WO2005055940A2 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
06/23/2005WO2005042444A3 Platinum complex and luminescent element
06/23/2005WO2005040129A3 Ccr3 receptor antagonists
06/23/2005WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor
06/23/2005WO2005026136A3 2, 2'-azino-bis-thiazolines and uses thereof as air- and water- stable radical precursors
06/23/2005WO2005025555A3 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
06/23/2005WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases
06/23/2005WO2002068380A8 Synthetic excitatory amino acids
06/23/2005US20050137240 Administering as a neuropeptide Y antagonist a 2-[(sulfonylaminoalkyl- or carbonylaminoalkyl)cycloalkyl(alkyl)amino]-5-phenylthiazole to treat obesity and eating disorders
06/23/2005US20050137239 Thiazole derivatives
06/23/2005US20050137238 Biphenyl derivatives; use in regulating and/or restoring skin lipid metabolism; for example, 1-methyl 7-{[4'-(2,4-dioxothiazolidin-5-ylmethyl)-biphenyl-3-ylmethyl]methylcarbamoyl}heptanoate, (S)-2-ethoxy-3-(3'-{[methyl-(6-oxo-6-phenyl hexanoyl) amino]methyl}biphenyl-4-yl)propionic acid
06/23/2005US20050137216 Heterocyclic sodium/proton exchange inhibitors and method
06/23/2005US20050137212 Hppars activators
06/23/2005US20050137191 Nitrate esters and their use for mitigating cellular damage
06/23/2005US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels
06/23/2005CA2549355A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same
06/23/2005CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005CA2549272A1 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005CA2548918A1 Alpha-amino acid derivatives and use thereof as medicines
06/23/2005CA2547404A1 Compositions comprising an hiv protease inhibitor
06/22/2005EP1544201A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
06/22/2005EP1543824A2 Thiazole derivatives to counter advanced glycation
06/22/2005EP1542981A1 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiaoles from cyclohexanes and cyclohexanones as intermediates
06/22/2005EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
06/22/2005CN1630637A Novel arylheteroalkylamine derivatives
06/22/2005CN1630632A Aromatic amino acid derivates and medicinal compositions
06/22/2005CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use
06/22/2005CN1630515A Compounds active at the glucocorticoid receptor II
06/22/2005CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation
06/22/2005CN1207288C Retroviral protease inhibiting compounds
06/22/2005CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
06/22/2005CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use
06/21/2005US6908948 Saturated nitrogen compounds, that bind to nucleic acids and generate chemical intermediates that splice the strands; prophylaxis of tumors and viral diseases
06/21/2005US6908939 Biaromatic ligand activators of PPARγ receptors
06/21/2005US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues
06/21/2005US6908935 Calcium receptor modulating agents
06/21/2005US6908884 For agriculture/horticulture/crops
06/17/2005CA2479432A1 Thiazole derivatives
06/16/2005WO2005054430A2 Hepatitis c virus inhibitors
06/16/2005WO2005054216A1 Novel anticancer agent “sulcoxin”
06/16/2005WO2005054215A1 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
06/16/2005WO2005054214A1 Methods of preparing compounds useful as protease inhibitors
06/16/2005WO2005054186A2 Methods for the preparation of stereoisomerically enriched amines
06/16/2005WO2005053735A1 Method of removing transition metals, especially from metathesis reaction products
06/16/2005WO2005053707A1 Blood flow promoters for cauda equina tissues
06/16/2005WO2005053610A2 Diamine and iminodiacetic acid hydroxamic acid derivatives
06/16/2005WO2005037928A3 Compounds for dual photodiagnosis and therapy
06/16/2005US20050131226 Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
06/16/2005US20050131042 HIV protease inhibiting compounds
06/16/2005US20050131035 Medicaments
06/16/2005US20050131018 Acetylene derivatives as inhibitors of histone deacetylase
06/16/2005US20050130982 4-isopropyl-2-methoxy-7-[4-(2-pyrimidyl)piperazinomethyl]-2,4,6-cycloheptatrien-1-one
06/16/2005US20050130974 Benzothiazole compositions and their use as ubiquitin ligase inhibitors
06/16/2005US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
06/16/2005US20050130970 Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters
06/16/2005US20050130941 Methods of treating alzheimer's disease
06/16/2005US20050129772 Using n-allyl-3-(2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylbutanoyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide
06/16/2005DE10351744A1 Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel Thiazolidinones, to their preparation and use as medicaments
06/16/2005CA2549290A1 Methods of preparing compounds useful as protease inhibitors
06/16/2005CA2549289A1 Methods for the preparation of stereoisomerically enriched amines
06/16/2005CA2547356A1 Diamine and iminodiacetic acid hydroxamic acid derivatives
06/16/2005CA2545582A1 5-(benz-(z)-ylidene)-thiazolidin-4-one derivatives as immunosuppressant agents
06/16/2005CA2539575A1 Method of removing transition metals, especially from metathesis reaction products
06/15/2005EP1539725A1 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
06/15/2005EP1539724A1 Amino benzothiazole compounds with nos inhibitory activity
06/15/2005EP1539723A1 Novel use of benzothiazole derivatives
06/15/2005EP1539722A1 Thiazole derivatives
06/15/2005EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
06/15/2005EP1539685A1 Mcp-1 receptor antagonists and method of use thereof
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1539151A1 Biaryl compounds having anti-infective activity
06/15/2005EP1349856B1 Isoindolin-1-one glucokinase activators
06/15/2005EP1311504B1 Tetrazolyl-phenyl acetamide glucokinase activators
06/15/2005EP1305301B1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
06/15/2005EP1020451B1 Anilide compounds and drugs containing the same
06/15/2005EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
06/15/2005CN1628108A Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate
06/15/2005CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
06/15/2005CN1626526A Compound of alpha, beta and beta, gamma unsaturation carboxylate class of possessing weeding activity
06/15/2005CN1626525A Process for the preparation of thiazole derivatives
06/15/2005CN1626521A Acceptor excitant of a class of pancreas hyperglycemia peptide-1, preparation method and usage
06/15/2005CN1626513A Organometallic complexes and organic electroluminescence device using the same
06/15/2005CN1206224C Substituted benzylthiazolidine-2,4-dione derivatives
06/14/2005US6906188 Method for synthesizing epothilones and epothilone analogs
06/14/2005US6906104 Aminediols for the treatment of Alzheimer's disease
06/14/2005US6906072 Central nervous system disorders
06/09/2005WO2005051974A2 Novel molecules for regulating cell death
06/09/2005WO2005051946A2 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
06/09/2005WO2005051932A1 Arylheterocycle derivative and agricultural or horticulrual bactericide and insecticide